Michael T. Dill

4.0k total citations · 1 hit paper
41 papers, 2.2k citations indexed

About

Michael T. Dill is a scholar working on Hepatology, Oncology and Molecular Biology. According to data from OpenAlex, Michael T. Dill has authored 41 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Michael T. Dill's work include Hepatitis C virus research (14 papers), interferon and immune responses (6 papers) and Hippo pathway signaling and YAP/TAZ (6 papers). Michael T. Dill is often cited by papers focused on Hepatitis C virus research (14 papers), interferon and immune responses (6 papers) and Hippo pathway signaling and YAP/TAZ (6 papers). Michael T. Dill collaborates with scholars based in Switzerland, United States and Germany. Michael T. Dill's co-authors include Markus H. Heim, Luigi Terracciano, Fernando D. Camargo, Zuzanna Makowska, Luigi Tornillo, David Buechel, Ravi Kiran Reddy Kalathur, Gerhard Christofori, Shuang Song and Caner Ercan and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The EMBO Journal.

In The Last Decade

Michael T. Dill

38 papers receiving 2.1k citations

Hit Papers

YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatoc... 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael T. Dill Switzerland 22 867 729 575 443 382 41 2.2k
Curtis Gumbs United States 20 1.3k 1.5× 316 0.4× 356 0.6× 175 0.4× 351 0.9× 45 2.7k
Susanne N. Weber Germany 22 1.1k 1.2× 218 0.3× 416 0.7× 174 0.4× 219 0.6× 68 2.0k
Neşe Atabey Türkiye 21 819 0.9× 353 0.5× 158 0.3× 238 0.5× 328 0.9× 60 1.6k
Angela Costantino Italy 23 1.8k 2.1× 921 1.3× 652 1.1× 119 0.3× 581 1.5× 61 3.2k
Elizabeth D. Fixman Canada 23 786 0.9× 361 0.5× 417 0.7× 96 0.2× 105 0.3× 41 2.2k
Béatrice Romagnolo France 20 2.0k 2.3× 264 0.4× 197 0.3× 240 0.5× 322 0.8× 36 3.0k
Hiroyuki Nishimori Japan 20 1.7k 1.9× 321 0.4× 150 0.3× 285 0.6× 339 0.9× 47 2.6k
Gengxi Hu China 25 1.3k 1.4× 145 0.2× 214 0.4× 236 0.5× 296 0.8× 40 1.8k
Pia Rantakari Finland 22 565 0.7× 140 0.2× 294 0.5× 161 0.4× 175 0.5× 46 1.5k

Countries citing papers authored by Michael T. Dill

Since Specialization
Citations

This map shows the geographic impact of Michael T. Dill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. Dill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. Dill more than expected).

Fields of papers citing papers by Michael T. Dill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael T. Dill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. Dill. The network helps show where Michael T. Dill may publish in the future.

Co-authorship network of co-authors of Michael T. Dill

This figure shows the co-authorship network connecting the top 25 collaborators of Michael T. Dill. A scholar is included among the top collaborators of Michael T. Dill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael T. Dill. Michael T. Dill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weykamp, Fabian, Katharina Seidensaal, Christoph Springfeld, et al.. (2025). Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancer. Radiation Oncology. 20(1). 23–23. 1 indexed citations
2.
Khaled, Najib Ben, Julia Schneider, Alexander Weich, et al.. (2025). Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real‐World Analysis of the IMMUreal Cohort. Alimentary Pharmacology & Therapeutics. 61(11). 1755–1766. 1 indexed citations
3.
Chang, De‐Hua, Philipp Mayer, Jakob Liermann, et al.. (2025). Longitudinal CE-MRI-based Siamese network with machine learning to predict tumor response in HCC after DEB-TACE. Cancer Imaging. 25(1). 104–104.
4.
Olkus, Alexander, Aurelie Tomczak, Anne Berger, et al.. (2024). Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data. Targeted Oncology. 19(2). 213–221. 9 indexed citations
5.
Dill, Michael T., et al.. (2023). Language Profile of the United States Physician Workforce: A Descriptive Study. Patient Education and Counseling. 109. 28–28.
6.
Wehling, Cyrill, Michael T. Dill, Alexander Olkus, et al.. (2021). Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities. Journal of Cancer Research and Clinical Oncology. 147(8). 2471–2481. 7 indexed citations
7.
Pepe-Mooney, Brian J., Michael T. Dill, Anna Alemany, et al.. (2019). Single-Cell Analysis of the Liver Epithelium Reveals Dynamic Heterogeneity and an Essential Role for YAP in Homeostasis and Regeneration. Cell stem cell. 25(1). 23–38.e8. 177 indexed citations
8.
Yuan, Wei-Chien, Brian J. Pepe-Mooney, Giorgio Giacomo Galli, et al.. (2018). NUAK2 is a critical YAP target in liver cancer. Nature Communications. 9(1). 4834–4834. 103 indexed citations
9.
Ariza, Jeanelle, et al.. (2017). Iron accumulation and dysregulation in the putamen in fragile X‐associated tremor/ataxia syndrome. Movement Disorders. 32(4). 585–591. 29 indexed citations
10.
Ariza, Jeanelle, et al.. (2017). Maternal autoimmune antibodies alter the dendritic arbor and spine numbers in the infragranular layers of the cortex. PLoS ONE. 12(8). e0183443–e0183443. 16 indexed citations
11.
Bernsmeier, Christine, Michael T. Dill, A. Provenzano, et al.. (2016). Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulation. Laboratory Investigation. 96(9). 972–980. 16 indexed citations
12.
Wieland, Stefan, Zuzanna Makowska, Benedetta Campana, et al.. (2013). Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver. Hepatology. 59(6). 2121–2130. 136 indexed citations
13.
Morikawa, Kenichi, Jérôme Gouttenoire, Céline Hernandez, et al.. (2013). Quantitative Proteomics Identifies the Membrane-Associated Peroxidase Gpx8 as a Cellular Substrate of the Hepatitis C Virus NS3–4A Protease. Hepatology. 59(2). 423–433. 37 indexed citations
14.
Frentzen, Anne, Anggakusuma, Engin Gürlevik, et al.. (2013). Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells. Hepatology. 59(1). 78–88. 34 indexed citations
15.
Duong, François H.T., Michael T. Dill, Matthias S. Matter, et al.. (2013). Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53. Carcinogenesis. 35(1). 114–122. 22 indexed citations
16.
Dill, Michael T., Sonja Rothweiler, Valentin Djonov, et al.. (2012). Disruption of Notch1 Induces Vascular Remodeling, Intussusceptive Angiogenesis, and Angiosarcomas in Livers of Mice. Gastroenterology. 142(4). 967–977.e2. 98 indexed citations
17.
Rau, Monika, Felix Stickel, Stefan Russmann, et al.. (2012). Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection. Journal of Hepatology. 58(4). 669–675. 35 indexed citations
18.
Dill, Michael T., Luigi Tornillo, Thorsten Fritzius, et al.. (2012). Constitutive Notch2 signaling induces hepatic tumors in mice. Hepatology. 57(4). 1607–1619. 94 indexed citations
19.
Dill, Michael T., François H.T. Duong, Julia E. Vogt, et al.. (2010). Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Response Than IL28B Genotype in Patients With Hepatitis C. Gastroenterology. 140(3). 1021–1031.e10. 201 indexed citations
20.
Smith, Roy G., Paige K. Besch, Michael T. Dill, & Veasy C. Buttram. (1979). Saliva as a Matrix for Measuring free Androgens: Comparison with Serum Androgens in Polycystic Ovarian Disease. Fertility and Sterility. 31(5). 513–517. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026